Corbus Pharmaceuticals Holdings Inc. (CRBP) stock plunged during current market. Let’s find out why?
Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) stock fell by 11.31% during the current trading session. By expanding on their core knowledge in immunology, Corbus is committed to linking innovation to their goal of helping lives by discovering novel medications that address inflammation, fibrosis, metabolism, and immuno-oncology. >> 7 Top Picks for the Post-Pandemic Economy << […]
